Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem
- 专利权人:
- Pierre Fabre Medicament
- 发明人:
- VACHER BERNARD,LE GRAND BRUNO
- 申请号：
- PL12759430
- 公开号：
- PL2755649T3
- 申请日:
- 2012.09.13
- 申请国别(地区):
- PL
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to the use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine or a pharmaceutically acceptable salt thereof for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for preventing and/or treating cardiotoxic effects caused by chemotherapy and/or radiation
- Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro- 2H-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases
- Use of 3-(R)-[3-(2-methoxyphenylthio)-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases
- USE OF 3-(R)-[3-(2-METHOXYPHENYLTHIO)-2-(S)-METHYL-PROPYL]AMINO-3, 4-DIHYDRO-2H-1,5- BENZOXATHIEPINE FOR TREATING CANCER AND IN PARTICULAR FOR PREVENTING AND/OR TREATING CANCER METASTASES
- USE OF VALBENAZINE FOR TREATING LEVODOPA-INDUCED DYSKINESIA
